Literature DB >> 28944325

Comparison of contrast-enhanced CT with diffusion -weighted MRI in the Evaluation of patients with acute biliary pancreatitis.

Mehmet İlhan1, Muhammet Üçüncü2, Ali Fuat Kaan Gök1, Gizem Öner1, Elidor Agolli3, Bahar Canbay1, Barış Bakır3, Recep Güloğlu1, Cemalettin Ertekin1.   

Abstract

OBJECTIVE: The aim of this study was to compare contrast-enhanced computed tomography with diffusion-weighted magnetic resonance imaging in the evaluation of patients with acute biliary pancreatitis.
MATERIAL AND METHODS: Fifty-three patients diagnosed with acute biliary pancreatitis, between February 2012 and July 2015, were evaluated using diffusion-weighted magnetic resonance imaging and magnetic resonance cholangiopancreatography to explain the elevation of cholestasis enzymes and bilirubin levels at "stanbul University. Contrast-enhanced computed tomography imaging was applied within 8 h following first evaluation. Demographic data, severity of pancreatitis, pancreatic apparent diffusion coefficient, and computed tomography severity index were compared. The significance of the results was evaluated using Statistical Package for the Social Sciences 21.0 program.
RESULTS: Median age was 53.39 (22-90) years in these 53 patients (26 were males and 27 were females). The mean Ranson criterion was 0.96 (0-4) and mean hospitalization duration was 16.02 (3-100) days. Twenty-eight patients were evaluated to have mild acute pancreatitis, whereas 16 were moderately severe and nine were severe based on the Revised Atlanta Classification. Mild pancreatitis score was 0.89, moderately severe pancreatitis score was 3.50, and severe pancreatitis score was 5.78 using the Balthazar score. Elevated C-reactive protein levels were not correlated with necrosis and the clinical severity score (p>0.05). There was no significant difference among the Balthazar score, magnetic resonance cholangiopancreatography-apparent diffusion coefficient score, and Revised Atlanta score in the evaluation of the severity of pancreatitis when the two techniques were compared. A statistically insignificant difference was found between the Balthazar score and magnetic resonance imaging results of clinically confirmed necrosis and non-necrosis patients.
CONCLUSION: It can be concluded that diffusion-weighted magnetic resonance imaging might be better than contrast-enhanced computed tomography in the diagnosis of acute pancreatitis as it avoids radiation exposure as well as the development of renal failure and pancreatitis aggravation due to the use of contrast for computed tomography. These results need to be confirmed with randomized prospective controlled studies.

Entities:  

Keywords:  DW MRI; contrast-enhanced computed tomography; pancreatitis; pancreatitis severity

Year:  2017        PMID: 28944325      PMCID: PMC5602304          DOI: 10.5152/UCD.2016.3573

Source DB:  PubMed          Journal:  Turk J Surg        ISSN: 2564-6850


  18 in total

1.  The early prediction of mortality in acute pancreatitis: a large population-based study.

Authors:  B U Wu; R S Johannes; X Sun; Y Tabak; D L Conwell; P A Banks
Journal:  Gut       Date:  2008-06-02       Impact factor: 23.059

2.  Severe acute pancreatitis admitted to intensive care unit: SOFA is superior to Ranson's criteria and APACHE II in determining prognosis.

Authors:  Füsun Adam; Canan Bor; Mehmet Uyar; Kubilay Demırağ; İlkin Çankayalı
Journal:  Turk J Gastroenterol       Date:  2013       Impact factor: 1.852

Review 3.  Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: a meta-analysis.

Authors:  Wei Huang; Kiran Altaf; Tao Jin; Jun-Jie Xiong; Li Wen; Muhammad A Javed; Marianne Johnstone; Ping Xue; Christopher M Halloran; Qing Xia
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

4.  APACHE-II score for assessment and monitoring of acute pancreatitis.

Authors:  M Larvin; M J McMahon
Journal:  Lancet       Date:  1989-07-22       Impact factor: 79.321

5.  The efficacy of diffusion-weighted imaging for the detection and evaluation of acute pancreatitis.

Authors:  Satoshi Shinya; Takamitsu Sasaki; Yoshifumi Nakagawa; Zhang Guiquing; Fumio Yamamoto; Yuichi Yamashita
Journal:  Hepatogastroenterology       Date:  2009 Sep-Oct

6.  Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

Authors:  Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege
Journal:  Gut       Date:  2012-10-25       Impact factor: 23.059

7.  Diffusion-weighted magnetic resonance imaging in autoimmune pancreatitis.

Authors:  Takao Taniguchi; Hisato Kobayashi; Koji Nishikawa; Etsushi Iida; Yoshihiro Michigami; Emiko Morimoto; Rikiya Yamashita; Ken Miyagi; Motozumi Okamoto
Journal:  Jpn J Radiol       Date:  2009-05-03       Impact factor: 2.374

Review 8.  Minimally Invasive Necrosectomy Techniques in Severe Acute Pancreatitis: Role of Percutaneous Necrosectomy and Video-Assisted Retroperitoneal Debridement.

Authors:  Jennifer A Logue; C Ross Carter
Journal:  Gastroenterol Res Pract       Date:  2015-10-26       Impact factor: 2.260

9.  Step-up approach and video assisted retroperitoneal debridement in infected necrotizing pancreatitis: A case complicated by retroperitoneal bleeding and colonic fistula.

Authors:  Eugene Lim; R S Sundaraamoorthy; David Tan; Hui-Seong Teh; Tzu-Jen Tan; Anton Cheng
Journal:  Ann Med Surg (Lond)       Date:  2015-07-23

10.  Evaluating the Ability of the Bedside Index for Severity of Acute Pancreatitis Score to Predict Severe Acute Pancreatitis: A Meta-Analysis.

Authors:  Yu-Xia Yang; Li Li
Journal:  Med Princ Pract       Date:  2015-11-28       Impact factor: 1.927

View more
  1 in total

1.  Comparison of magnetic resonance imaging and computed tomography in the diagnosis of acute pancreatitis: a systematic review and meta-analysis of diagnostic test accuracy studies.

Authors:  Hui Sun; Sha Jian; Bo Peng; Jian Hou
Journal:  Ann Transl Med       Date:  2022-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.